System C Healthcare plc
19 September 2006
This announcement replaces RNS no: 1705J released on 19th September 2006 at
14:22 as it there was an error in the wording.
System C Healthcare plc
Directorate Change
We are delighted to announce the appointment of Dr John Forrest as Senior
Independent Director at System C Healthcare Ltd. John joined System C as a Non
Executive Director in February 2005. He graduated with an MA from Cambridge
University and a DPhil from Oxford University. In 1984 he joined Marconi Defence
Systems as Technical Director and later became Director of Engineering at the
Independent Broadcasting Authority. He led the privatisation to create the
communications company NTL, becoming its first Chief Executive. In 1996 he
joined the venture capital company, 3i plc, and served on the board and its
associated committees until 2004. John is Chairman of Mediwatch plc and
Pro-Chancellor of the University of Surrey.
For further information please contact
Jim Horsburgh, Chairman Tel: 01622 691616
Emma Burdett, Maitland Tel: 020 7379 5151
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.